PS
NXTM

Portfolio Solutions’s NxStage Medical Inc. NXTM Stock Holding History

Portfolio Solutions’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-245
Closed -$6K – 194
2018
Q1 		$6K Hold
245
– – ﹤0.01% 163
2017
Q4 		$6K Hold
245
– – ﹤0.01% 155
2017
Q3 		$7K Hold
245
– – ﹤0.01% 141
2017
Q2 		$6K Hold
245
– – ﹤0.01% 140
2017
Q1 		$7K Buy
+245
New +$6.77K ﹤0.01% 151

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Portfolio Solutions's NXTM Position: Q2 2018 in Review

Portfolio Solutions sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 245 shares — an estimated $6K sold.

Portfolio Solutions first reported a position in NXTM in Q1 2017 and held it in 5 quarters. The position peaked at $7K in Q3 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • Portfolio Solutions reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • Portfolio Solutions sold 245 NxStage Medical Inc. shares in Q2 2018, an estimated $6K.
  • Portfolio Solutions first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 5 quarters.
  • Portfolio Solutions's NxStage Medical Inc. position peaked at $7K in Q3 2017.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.